391 related articles for article (PubMed ID: 29416702)
1. Drug resistance related to aberrant glycosylation in colorectal cancer.
Very N; Lefebvre T; El Yazidi-Belkoura I
Oncotarget; 2018 Jan; 9(1):1380-1402. PubMed ID: 29416702
[TBL] [Abstract][Full Text] [Related]
2. The Role of Glycosyltransferases in Colorectal Cancer.
Fernández-Ponce C; Geribaldi-Doldán N; Sánchez-Gomar I; Quiroz RN; Ibarra LA; Escorcia LG; Fernández-Cisnal R; Martinez GA; García-Cózar F; Quiroz EN
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070747
[TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen is a sialyl Lewis x/a carrier and an E‑selectin ligand in non‑small cell lung cancer.
Ferreira IG; Carrascal M; Mineiro AG; Bugalho A; Borralho P; Silva Z; Dall'olio F; Videira PA
Int J Oncol; 2019 Nov; 55(5):1033-1048. PubMed ID: 31793656
[TBL] [Abstract][Full Text] [Related]
4. Glycan analysis of colorectal cancer samples reveals stage-dependent changes in CEA glycosylation patterns.
Zhao Q; Zhan T; Deng Z; Li Q; Liu Y; Yang S; Ji D; Li Y
Clin Proteomics; 2018; 15():9. PubMed ID: 29507546
[TBL] [Abstract][Full Text] [Related]
5. [Recent advances in glycopeptide enrichment and mass spectrometry data interpretation approaches for glycoproteomics analyses].
Liu L; Qin H; Ye M
Se Pu; 2021 Oct; 39(10):1045-1054. PubMed ID: 34505426
[TBL] [Abstract][Full Text] [Related]
6. The Importance of Determining Preoperative Serum Concentration of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Assessing the Progression of Colorectal Cancer.
Halilovic E; Rasic I; Sofic A; Mujic A; Rovcanin A; Hodzic E; Kulovic E
Med Arch; 2020 Oct; 74(5):346-349. PubMed ID: 33424087
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
[TBL] [Abstract][Full Text] [Related]
8. Carcinoembryonic Antigen (CEA) and Hepatic Metastasis in Colorectal Cancer: Update on Biomarker for Clinical and Biotechnological Approaches.
Campos-da-Paz M; Dórea JG; Galdino AS; Lacava ZGM; de Fatima Menezes Almeida Santos M
Recent Pat Biotechnol; 2018; 12(4):269-279. PubMed ID: 30062978
[TBL] [Abstract][Full Text] [Related]
9. The Cancer-Associated Antigens Sialyl Lewis
Dall'Olio F; Pucci M; Malagolini N
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771437
[TBL] [Abstract][Full Text] [Related]
10. Glycan motif profiling reveals plasma sialyl-lewis x elevations in pancreatic cancers that are negative for sialyl-lewis A.
Tang H; Singh S; Partyka K; Kletter D; Hsueh P; Yadav J; Ensink E; Bern M; Hostetter G; Hartman D; Huang Y; Brand RE; Haab BB
Mol Cell Proteomics; 2015 May; 14(5):1323-33. PubMed ID: 25733690
[TBL] [Abstract][Full Text] [Related]
11. Circulating sialyl Lewis(x), sialyl Lewis(a), and sialyl Tn antigens in colorectal cancer patients: multivariate analysis of predictive factors for serum antigen levels.
Nakagoe T; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Kurosaki N; Yasutake T; Ayabe H
J Gastroenterol; 2001 Mar; 36(3):166-72. PubMed ID: 11291879
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus X protein specially regulates the sialyl lewis a synthesis among glycosylation events for metastasis.
Chung TW; Kim SJ; Choi HJ; Song KH; Jin UH; Yu DY; Seong JK; Kim JG; Kim KJ; Ko JH; Ha KT; Lee YC; Kim CH
Mol Cancer; 2014 Sep; 13():222. PubMed ID: 25255877
[TBL] [Abstract][Full Text] [Related]
13. Glycosylation characteristics of colorectal cancer.
Holst S; Wuhrer M; Rombouts Y
Adv Cancer Res; 2015; 126():203-56. PubMed ID: 25727149
[TBL] [Abstract][Full Text] [Related]
14. Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.
Thomas D; Rathinavel AK; Radhakrishnan P
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188464. PubMed ID: 33157161
[TBL] [Abstract][Full Text] [Related]
15. Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging.
Khan K; Athauda A; Aitken K; Cunningham D; Watkins D; Starling N; Cook GJ; Kalaitzaki E; Chau I; Rao S
Oncologist; 2016 Dec; 21(12):1502-1508. PubMed ID: 27742904
[TBL] [Abstract][Full Text] [Related]
16. Carbohydrate antigen 19-9 plus carcinoembryonic antigen for prognosis in colorectal cancer: An observational study.
Lee JO; Kim M; Lee JH; Kim Y; Lim HK; Kwon YH; Shin R; Park JW; Ryoo SB; Park KJ; Jeong SY
Colorectal Dis; 2023 Feb; 25(2):272-281. PubMed ID: 36226485
[TBL] [Abstract][Full Text] [Related]
17. Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients.
Saeland E; Belo AI; Mongera S; van Die I; Meijer GA; van Kooyk Y
Int J Cancer; 2012 Jul; 131(1):117-28. PubMed ID: 21823122
[TBL] [Abstract][Full Text] [Related]
18. Side population cells derived from hUCMSCs and hPMSCs could inhibit the malignant behaviors of Tn
Hu W; Ding R; Wang M; Huang P; Wei X; Hu X; Hu T
Stem Cell Res Ther; 2023 May; 14(1):145. PubMed ID: 37237420
[TBL] [Abstract][Full Text] [Related]
19. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
Das V; Kalita J; Pal M
Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
[TBL] [Abstract][Full Text] [Related]
20. Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer.
Ren SN; Zhang ZY; Guo RJ; Wang DR; Chen FF; Chen XB; Fang XD
World J Gastroenterol; 2023 Apr; 29(13):1911-1941. PubMed ID: 37155531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
